X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51) 51
index medicus (51) 51
endocrinology & metabolism (50) 50
diabetes (40) 40
female (35) 35
type 2 diabetes (31) 31
middle aged (29) 29
male (28) 28
adult (25) 25
clinical trials (23) 23
diabetes mellitus (21) 21
insulin (20) 20
hypoglycemic agents - therapeutic use (19) 19
aged (18) 18
diabetes mellitus, type 2 - drug therapy (18) 18
glucose (17) 17
metformin (16) 16
safety (16) 16
abridged index medicus (14) 14
hypoglycemia (14) 14
care and treatment (13) 13
risk (13) 13
prevention (12) 12
treatment outcome (12) 12
hemoglobin (11) 11
risk factors (11) 11
body weight (10) 10
original (10) 10
blood glucose - metabolism (9) 9
diabetes mellitus, type 2 - blood (9) 9
diabetes mellitus, type 2 - prevention & control (9) 9
drug therapy (9) 9
glycemic control (9) 9
analysis (8) 8
association (8) 8
double-blind method (8) 8
glycated hemoglobin a - metabolism (8) 8
hypoglycemic agents - administration & dosage (8) 8
hypoglycemic agents - adverse effects (8) 8
internal medicine (8) 8
life-style intervention (8) 8
liraglutide (8) 8
medicine & public health (8) 8
mellitus (8) 8
metformin - therapeutic use (8) 8
patients (8) 8
peptides - administration & dosage (8) 8
usage (8) 8
adults (7) 7
article (7) 7
cardiovascular disease (7) 7
double-blind (7) 7
endocrine system diseases (7) 7
hypoglycemic agents (7) 7
incidence (7) 7
medicine, general & internal (7) 7
research (7) 7
therapy (7) 7
blood glucose - drug effects (6) 6
body mass index (6) 6
dextrose (6) 6
efficacy (6) 6
exenatide (6) 6
health aspects (6) 6
hypoglycemic agents - pharmacology (6) 6
impaired glucose-tolerance (6) 6
nutritional and metabolic diseases (6) 6
original articles (6) 6
placebo-controlled trial (6) 6
time factors (6) 6
women (6) 6
blood pressure (5) 5
body weight - drug effects (5) 5
cardiovascular-disease (5) 5
diabetes mellitus, type 2 - epidemiology (5) 5
diabetes therapy (5) 5
diet (5) 5
dosage and administration (5) 5
drug combinations (5) 5
endocrinology (5) 5
epidemiology (5) 5
follow-up studies (5) 5
glp-1 (5) 5
glp-1 receptor agonists (5) 5
glycosylated hemoglobin (5) 5
hypoglycemia - chemically induced (5) 5
insulin glargine (5) 5
insulin resistance (5) 5
medical research (5) 5
metabolic syndrome (5) 5
obesity (5) 5
original article (5) 5
peptides - adverse effects (5) 5
peptides - therapeutic use (5) 5
pioglitazone (5) 5
type-2 diabetes-mellitus (5) 5
weight loss - drug effects (5) 5
aged, 80 and over (4) 4
basal insulin (4) 4
blood glucose - analysis (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Diabetes, ISSN 0012-1797, 06/2019, Volume 68, Issue Supplement 1, p. 147
Patients (pts) (n=1012) with T2D (A1C 7-11%) on oral antidiabetic drugs (OADs) were randomized 1:1 to open label IDegLira or IGlar U100 in a 104 week trial to... 
Hypoglycemia | Insulin | Patients | Diabetes mellitus
Journal Article
DIABETES CARE, ISSN 0149-5992, 09/2019, Volume 42, Issue 9, pp. 1724 - 1732
OBJECTIVE This trial compared the efficacy and safety of the first oral glucagon-like peptide 1 (GLP-1) receptor agonist, oral semaglutide, as monotherapy with... 
GLUCAGON-LIKE PEPTIDE-1 | ASSOCIATION | RECEPTOR AGONISTS | ENDOCRINOLOGY & METABOLISM | Drugs | Effectiveness | Glucagon | Diabetes mellitus | Body weight | Weight loss | Clinical trials | Body weight loss | Patients | Randomization | Diet | Safety engineering | Agonists | Research design | Diabetes | Safety | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1
Journal Article
Diabetes, ISSN 0012-1797, 06/2019, Volume 68, Issue Supplement 1, p. 131
Diabetes prevalence in older people is increasing and older people have an increased risk of hypoglycemia. Results are shown here of subgroup analyses in... 
Renal function | Diabetes | Hypoglycemia | Insulin | Diabetes mellitus | Older people
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 10/2019, Volume 21, Issue 10, pp. 2203 - 2210
Regulatory guidelines describe the use of estimands in designing and conducting clinical trials. Estimands ensure alignment of the objectives with the design,... 
PIONEER | regulatory guidance | Diabetes | GLP‐1 receptor agonists | estimand | oral semaglutide | CHOOSING ESTIMANDS | GLP-1 receptor agonists | ENDOCRINOLOGY & METABOLISM | Clinical trials | Diabetes mellitus (non-insulin dependent) | Patients | Diabetes mellitus | Review
Journal Article
Diabetes care, ISSN 0149-5992, 08/2019, p. dc190901
GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study) is a 36-center unmasked, parallel treatment group, randomized controlled... 
Journal Article
Diabetes Spectrum, ISSN 1040-9165, 11/2018, Volume 31, Issue 4, pp. 336 - 342
Metformin, an established therapy for the treatment of type 2 diabetes, has demonstrated safety and effectiveness in the prevention or delay of type 2 diabetes... 
Type 2 diabetes | Prevention | Usage | Care and treatment | Safety and security measures | Metformin
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.